Active substance
Podophyllotoxin
- SFDA 1
- NHS prices 2
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| WARTEC 0.15% W-W CREAM | 0.15 % | Cream · Topical | 5 Tube | SAR 63.60 | NCE · Prescription | STIEFEL LABORATORIES | Valid |
Indications — CHI Daman Drug Formulary
ANOGENITAL (VENEREAL) WARTS; MOLLUSCUM CONTAGIOSUM
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Podophyllotoxin 0.15% cream | £17.83 | 5 gram | 1 Oct 2026 |
| NHS Drug Tariff | Podophyllotoxin 0.5% solution | £14.86 | 3 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 13.4. Dermatological medicines > Medicines affecting skin differentiation and proliferation · core
Therapeutic equivalent to podophyllum resin for Plantar warts; Therapeutic equivalent to podophyllum resin for Anogenital warts
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.